Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer.
about
Phosphorylation of multifunctional nucleolar protein nucleophosmin (NPM1) by aurora kinase B is critical for mitotic progressionAurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A ReviewAurora kinases in head and neck cancerOverexpression of hnRNPC2 induces multinucleation by repression of Aurora B in hepatocellular carcinoma cellsAdult murine cardiomyocytes exhibit regenerative activity with cell cycle reentry through STAT3 in the healing process of myocarditis.Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitroHSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patientsReversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagyExpression of aurora kinase A and B in chondrosarcoma and its relationship with the prognosis.Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technologyPARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer.Inhibition of Aurora-B suppresses osteosarcoma cell migration and invasion.Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.An overview of the spindle assembly checkpoint status in oral cancer.Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy.Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc.Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.Aberrantly expressed AURKC enhances the transformation and tumourigenicity of epithelial cells.MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomasExpression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies.Expression of Aurora-B and FOXM1 predict poor survival in patients with nasopharyngeal carcinoma.Biologic therapy in head and neck cancer: a road with hurdles.Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer.Expression patterns of cell cycle proteins in the livers of rats treated with hepatocarcinogens for 28 days.RNA interference-mediated knockdown of Aurora-B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3-kinase/Akt signaling pathway.High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan.Altered expression of Aurora kinases in Arabidopsis results in aneu- and polyploidization.The Effect of Aurora Kinase Inhibitor on Adhesion and Migration in Human Breast Cancer Cells and Clinical Implications.Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer.A novel microRNA, hsa-miR-6852 differentially regulated by Interleukin-27 induces necrosis in cervical cancer cells by downregulating the FoxM1 expression.The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma.Kinase-targeted cancer therapies: progress, challenges and future directions.Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor Danusertib.Aurora B expression and histone variant H1.4S27 phosphorylation are no longer coordinated during metaphase in aneuploid colorectal carcinomas.High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications.
P2860
Q24298187-ECEA1C1F-2ABF-4375-B7A3-B9AA5E1C22D2Q26783412-4A7A69AC-C8B8-462C-8519-64525F3BEACCQ28654389-A3A5BDE9-84B5-4B7A-86B8-1FB6F9FA1CBAQ28708963-C66DDA85-A5AF-4B77-A72F-F6B5A9F6AAE4Q33684123-07BA77DE-2040-41EC-8C37-B26019B7807CQ33962378-73B7B636-CB08-4DD1-B86A-998F64B6E36EQ35742468-FADA460C-9CF6-45A1-BC2F-4ED868A117EAQ35822375-68B2C7C5-230B-4B0E-B8E5-08887F628EE7Q36367628-E696DCE6-37E6-4C86-AB58-11463B31E15DQ36414478-ECDCA154-449C-4C6A-B9F6-BC539110392AQ37109876-C10F8F09-1810-4F2D-AF53-C539822B9C37Q37575064-95086887-CB9C-4B9C-B933-6E927283151EQ38030445-AA27D530-83A9-41F8-B854-92DD5FC54152Q38101000-077F6260-F4DC-4C4E-933A-E7AC7089CE6BQ38226287-7AD18395-AB30-48DB-8ED0-EC3C9CECD8B0Q38894287-28502815-C95A-40DA-BA6A-4966B9A04457Q38939084-6880B0B1-353A-4AEC-A79D-08E9F85557C0Q39558101-47BDE34A-BFEF-446C-9643-F1F47A3569D2Q39704126-3115BE6D-79AD-42D9-BC0E-4A602D33B519Q39734794-A8422406-EBA9-4628-8DA3-F6D2AA30CAA7Q39990156-078182FB-F663-4C4D-9553-82AEFE8D0A83Q40978522-13FD6030-082F-4F92-A764-3C0F6E8DB0DCQ41463339-4E58805F-79C8-4089-BEBD-C8C89FB761BFQ41730924-77557FBE-E7BA-4ED2-937D-063920AE5410Q42213295-2D22F7EC-76F2-4792-9480-C61D17B305A1Q42225405-7586687D-C8F4-415C-8284-FE84BD8F6C51Q42712928-DF3E0CEB-3F22-418B-87A1-29C99DD68351Q42931095-2A3F8CE5-277E-4C47-8E9B-23F87C5B9888Q43719036-FCE18F16-9BF1-4A44-8896-EA52FE096AD3Q44664422-D6700116-5915-4CF0-BC07-F03CEDFB8D5CQ46364752-A6157D06-FAE0-4AD1-B927-E13020B42759Q46916025-3CA3711B-D4D8-4E35-BB88-F9A307CF448BQ47552205-D581C5D4-A3BB-4C79-9954-AC12A3FE8FF0Q47917582-5B93E281-07B6-460A-A406-45399B2C60CFQ49887882-94F02A6A-A5F3-4EFF-AF79-F34BF1C8F3A5Q52723943-6A251ED1-D84D-48EA-A4C1-69C668622672Q52967182-EC4BEDFF-0484-4BAA-80F3-48F119A2BFC4Q53187326-328DAD09-77BD-4A3B-AF1A-7BE64A8BF300Q53277143-32FF8B4A-C9F8-4599-B90F-DE36B8896DD1Q54614871-C7A2441C-E9E6-43DF-B040-495B504539E6
P2860
Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aurora-B expression and its co ...... and metastasis in oral cancer.
@ast
Aurora-B expression and its co ...... and metastasis in oral cancer.
@en
Aurora-B expression and its co ...... and metastasis in oral cancer.
@nl
type
label
Aurora-B expression and its co ...... and metastasis in oral cancer.
@ast
Aurora-B expression and its co ...... and metastasis in oral cancer.
@en
Aurora-B expression and its co ...... and metastasis in oral cancer.
@nl
prefLabel
Aurora-B expression and its co ...... and metastasis in oral cancer.
@ast
Aurora-B expression and its co ...... and metastasis in oral cancer.
@en
Aurora-B expression and its co ...... and metastasis in oral cancer.
@nl
P2093
P1433
P1476
Aurora-B expression and its co ...... and metastasis in oral cancer.
@en
P2093
B S M S Siriwardena
Fumio Shimamoto
Guangying Qi
Ikuko Ogawa
Masaaki Tatsuka
Mutsumi Miyauchi
Takashi Takata
P2888
P304
P356
10.1007/S00428-006-0360-9
P50
P577
2007-01-19T00:00:00Z